Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As with injectable Wegovy, most patients will start with the lowest dose and ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price. | ...

Semaglutide, the active ingredient in the anti-obesity drug Wegovy, offers cardiovascular benefits for patients without diabetes who have established heart disease, but price reductions would be ...

With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...

“GLP‑1s have effectively created a third pillar of pharmacy spend and most employers don't yet have a mature playbook to manage it,” Conway said, adding that over half of employers now cite GLP‑1s as ...

The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing ...

Goodpath, the virtual integrative care provider for chronic conditions, today announced direct-to-employer (DTE) and self-pay access to Wegovy (R) , including both injectable and newly-approved oral ...

Oral Wegovy reshapes GLP-1 costs: cash pay can be cheaper, insurance pricing often matches shots, and coverage hinges on employer benefits and coding.

Novo Nordisk (NVO) on Wednesday announced new late-stage trial data to highlight blood sugar control and cardiovascular benefits associated with an oral version of its popular GLP-1 therapy, ...

Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.